$10.29
N/A
Ult. Agg.: Oct 13, 8:50 AM
$10.48
0.191.85%
Puma Biotechnology (PBYI) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Puma Biotechnology (PBYI) ha pubblicato l'ultima guidance il agosto 6, 2026 per Q3 2026. La società ha previsto un fatturato pari a $56M - $59M per il periodo.
Rispetto alle previsioni precedenti, Puma Biotechnology {{epsDirection}} ha modificato le sue previsioni di fatturato da un intervallo precedente di {{epsPriorRange}}.
Puma Biotechnology ha pubblicato {{revenueDirection}} aggiornamenti delle previsioni tra il {{revenuePriorRange}} e il Puma Biotechnology. 30
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.07 | $-0.14 | $0.21 | $0.08 |
| Actual | $0.19 | $-0.04 | $0.29 | $0.21 |
| Surprise | +171.4% | +71.4% | +38.1% | +162.5% |
| Revenue | ||||
| Estimate | $53.1M | $41.4M | $68.3M | $49.9M |
| Actual | $53.6M | $44.8M | $75.5M | $54.5M |
| Surprise | +1.01% | +8.10% | +10.5% | +9.11% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.11 | $0.25 | $0.04 | $0.07 |
| Revenue | ||||
| Consensus | $57.4M | $14.0M | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $0.19 | $0.07 | 171.4 % |
| Q1 | May 7, 2026 | $-0.04 | $-0.14 | 71.4 % |
| Q4 | Feb 26, 2026 | $0.29 | $0.21 | 38.1 % |
| Q3 | Nov 6, 2025 | $0.21 | $0.08 | 162.5 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $53.60M | $53.07M | 1.01 % |
| Q1 | May 7, 2026 | $44.80M | $41.44M | 8.10 % |
| Q4 | Feb 26, 2026 | $75.50M | $68.30M | 10.5 % |
| Q3 | Nov 6, 2025 | $54.50M | $49.95M | 9.11 % |